InsidersTradesSigma
Browse the full record of transactions filed by Corin Denis, Chief Executive Officer. Director active across 1 companies, notably Q BioMed Inc.. Cumulatively, 1 disclosures have been logged. The latest transaction was filed on 26 May 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Denis Corin is the Chief Executive Officer of Q BioMed Inc. He is responsible for the strategic and operational direction of the company, focusing on innovation in the biopharmaceutical sector. His experience enables him to lead initiatives aimed at developing new treatments and improving healthcare quality.